Skip to main content

Table 2 CYP3A4 inducers and inhibitors

From: Lapatinib-capecitabine versus capecitabine alone as radiosensitizers in RAS wild-type resectable rectal cancer, an adaptive randomized phase II trial (LaRRC trial): study protocol for a randomized controlled trial

Drug class

Agent

Wash-out

CYP3A4 inducers

Antibiotics

All rifamycin agents (e.g., rifampicin, rifabutin, rifapentine)

14 days

Anticonvulsants

Phenytoin, carbamazepine, barbiturates (e.g., phenobarbital)

Antiretrovirals

Efavirenz, nevirapine

Glucocorticoids (oral)

Cortisone (>50 mg), hydrocortisone (>40 mg), prednisone (>10 mg), methylprednisone (>8 mg), dexamethasone (>1.5 mg)

Not Applicable

Others

St. John’s wort (Hypericum perforatum), modafinil

Not Applicable

CYP3A4 inhibitors

Antibiotics

Clarithromycin, erythromycin, troleandomycin

7 days

Antifungals

Itraconazole, ketoconazole, fluconazole (>150 mg/d), voriconazole

Antiretrovirals, protease inhibitors

Delavirdine, nelfinavir, amprenavir, ritonavir, indinavir, saquinavir, lopinivir

Calcium channel blockers

Verapamil, diltiazem

Antidepressants

Nefazodone, fluvoxamine

GI agents

Cimetidine, aprepitant

Others

Grapefruit, grapefruit juice

Amiodarone

6 months

Miscellaneous

Antacids

Mylanta®, Maalox®, Tums®, Rennie®

1 h before and after dosing

Herbal or dietary supplements

Ginkgo biloba, grape seed, valerian, ginseng, echinacea, evening primrose oil

14 days